FDA Inspection
Auro Pharmacies, Inc.Auro Pharmacies, Inc. – FDA Inspection, Aug 2, 2018
Record Details
This FDA Inspection record concerns Auro Pharmacies, Inc., with an inspection on August 2, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Andrew K. Haack (FDA Associated Person)
- Karthikeyan Kanakarajan (Issuing Officer)
- Kenneth O. Gee (FDA Associated Person)
View Company Profile
ID · 45a3d6ef-9da5-451f-b88a-201a185ae908
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1061744
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Auro Pharmacies, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Auro Pharmacies, Inc.
- FDA Inspection 1177654 - 2022-08-12
- FDA Inspection 948676 - 2015-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.